Brixner Diana I, Oderda Gary M, Roland Carl L, Rublee Dale A
Department of Pharmacotheraphy, University of Utah, Salt Lake City, UT 84112, USA.
J Pain Palliat Care Pharmacother. 2006;20(1):5-13.
Data from the U.S. Centers for Medicare and Medicaid Services' Medicaid database were analyzed to define recent trends in the use and cost of opioid medications United States as a whole and in seven states between 1998 and 2003. Over this time period, total Medicaid prescriptions for opioids have nearly doubled and, in nominal terms, expenditures have nearly tripled. The morphine derivatives account for the largest share of these increases. By 2003, opioids represented about a four percent share of all Medicaid prescription drugs. Variations among the states in per-enrollee spending on opioids are substantial. The appropriateness of these variations is unknown.
分析了美国医疗保险和医疗补助服务中心医疗补助数据库的数据，以确定1998年至2003年期间美国整体以及七个州阿片类药物的使用和成本的近期趋势。在此期间，医疗补助计划中阿片类药物的总处方量几乎翻了一番，按名义计算，支出几乎增长了两倍。吗啡衍生物在这些增长中占最大份额。到2003年，阿片类药物约占所有医疗补助处方药的4%。各州在阿片类药物人均支出方面存在很大差异。这些差异是否合理尚不清楚。
